Global Drug Delivery Devices Market Segmentation, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Inhalers, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare, and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy) - Industry Trends and Forecast to 2032
Drug Delivery Devices Market Size
The global drug delivery devices market size was valued at USD 1888.52 billion in 2024 and is expected to reach USD 3495.52 billion by 2032,at a CAGR of 8.00% during the forecast period
This growth is driven by factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, aging global population
Drug Delivery Devices Market Analysis
Drug delivery devices are medical devices designed to deliver medications to the body in a controlled and targeted manner, enhancing their efficacy, safety, and patient compliance
These devices can be external, such as inhalers, injectors, and pumps, or internal such as implantable devices, and are used to administer a wide range of medications, including small molecules, biologics, and vaccines
North America is expected to dominate the drug delivery devices market with 32.9% due to well-established healthcare sector, dedication to innovation, advanced infrastructure, strong R&D focus, and high prevalence of chronic conditions
Asia-Pacific is expected to be the fastest growing region in the drug delivery devices market during the forecast period due to rising disposable incomes, improving healthcare infrastructure, and strong economic growth in emerging economies such as Japan, China, and India
Inhaler’s segment is expected to dominate the market with a market share of 24.4% due to its demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions
Report Scope and Drug Delivery Devices Market Segmentation
Attributes
Drug Delivery Devices Key Market Insights
Segments Covered
By Product Type: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Inhalers, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery
By End User: Hospitals, Home Healthcare, Clinics, Community Healthcare and Others
By Distribution Channel: Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Drug Delivery Devices Market Trends
“Integration of Smart and Needle-Free Technologies”
The adoption of smart drug delivery devices is increasing, with features such as bluetooth connectivity, dose tracking, and reminder systems enhancing patient adherence and enabling remote monitoring
Needle-free injectors are gaining popularity due to their pain-free nature, enhanced patient comfort, and convenience
Wearable drug delivery devices, such as insulin patches and pumps, are becoming increasingly popular, offering continuous or intermittent doses of medication
The integration of digital technologies into drug delivery devices allows for real-time monitoring and remote control, improving patient outcomes
Advancements in personalized medicine are driving the development of targeted drug delivery systems, enhancing the efficacy of treatments
Drug Delivery Devices Market Dynamics
Driver
“Rising Prevalence of Chronic Diseases”
The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is driving the demand for effective drug delivery devices
Chronic conditions often require long-term medication, necessitating reliable and user-friendly drug delivery systems
The global aging population is more susceptible to chronic diseases, further escalating the need for efficient drug delivery solutions
Effective drug delivery systems can reduce healthcare costs by improving treatment adherence and reducing hospital visits
Innovations in drug delivery technologies are improving the management of chronic diseases, enhancing patient quality of life
Opportunity
“Expansion into Emerging Markets”
Countries in Asia-Pacific and Latin America present significant growth opportunities due to improving healthcare infrastructure and rising disposable incomes
Increased market penetration in these regions can lead to higher adoption rates of drug delivery devices
Establishing manufacturing facilities in emerging markets can reduce production costs and improve supply chain efficiency
Supportive government policies and investments in healthcare further propel market expansion in these regions
Tailoring drug delivery devices to meet the specific needs of populations in emerging markets can enhance adoption and effectiveness
Restraint/Challenge
“Stringent Regulatory Requirements”
Varying and stringent regulatory requirements across regions can delay product approvals and market entry
Extended approval timelines increase development costs and time to market
Meeting diverse regulatory standards incurs significant compliance costs for manufacturers
Regulatory barriers can limit access to certain markets, hindering global expansion efforts
Stringent regulations may slow down the introduction of innovative drug delivery solutions
Drug Delivery Devices Market Scope
The market is segmented on the basis of product type, end user, and distribution channel
Segmentation
Sub-Segmentation
By Product Type
Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Inhalers
Ophthalmic Drug Delivery
Nasal Drug Delivery
Pulmonary Drug Delivery
Transmucosal Drug Delivery
Implantable Drug Delivery
By End user
Hospitals
Home Healthcare
Clinics
Community Healthcare
Others
By Distribution Channel
Direct Tenders
Hospital Pharmacies
Pharmacy Stores
Online Pharmacy
In 2025, the inhalers is projected to dominate the market with a largest share in product type segment
The inhalers segment is expected to dominate the Drug Delivery Devices market with the largest share of 24.4% in 2025due to its demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions. These inhalers, which do not emit hydrofluorocarbon gases, offer the same efficacy while reducing environmental impact.
The hospital is expected to account for the largest share during the forecast period in end-user market
In 2025, the hospital segment is expected to dominate the market with the largest market share of 29.5% due to its rising demand for surgical interventions and preventive procedures. This surge is largely due to the growing number of surgeries, such as angioplasties, organ transplants, and trauma-related operations, all of which require precise and controlled drug administration.
Drug Delivery Devices Market Regional Analysis
“North America Holds the Largest Share in the Drug Delivery Devices Market”
North America is the leading region in the global drug delivery devices market, holding a substantial share of 32.9%
The region boasts advanced healthcare systems, facilitating the adoption of innovative drug delivery technologies
Favorable regulations and approvals from agencies such as the FDA accelerate the introduction of new devices
High rates of chronic conditions such as diabetes and cardiovascular diseases drive the demand for efficient drug delivery solutions
An increasing elderly population necessitates long-term medication management, boosting the market for drug delivery devices
“Asia-Pacific is Projected to Register the Highest CAGR in the Drug Delivery Devices Market”
The Asia-Pacific region is projected to experience the highest growth rate in the drug delivery devices market during the forecast period
Rapid economic growth in countries such as China and India enhances healthcare access and infrastructure
A large and aging population increases the demand for chronic disease management solutions
The region serves as a global manufacturing hub, reducing production costs and making devices more affordable
Supportive government policies and investments in healthcare further propel market expansion
Drug Delivery Devices Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
Latest Developments in Global Drug Delivery Devices Market
In January 2025, PhillipsMedisize, a Molex company, completed the acquisition of Vectura Group Ltd., enhancing its inhalation drug delivery capabilities. This strategic move adds expertise in dry powder inhalers, metered dose inhalers, nasal inhalers, and nebulizers, broadening Phillips Medisize's portfolio in pharmaceutical device design and manufacturing
In January 2025, Nipro and Nemera announced the successful compatibility testing of Nemera's UniSpray device with Nipro's unit-dose microvials. This collaboration aims to enhance nasal drug delivery by combining Nipro's precision glass vials with Nemera's intuitive nasal spray device, offering a reliable solution for single-dose nasal medication administration
In October 2024, Aptar Pharma, a global leader in drug delivery systems, acquired all device technology assets from the proprietary portfolio of SipNose Nasal Delivery Systems, a company focused on intranasal delivery platforms for local, systemic, and central nervous system indications. The acquisition will expand Aptar Pharma’s patent product portfolio and support new product development
In February 2023, InnovationZed, one of the leading key players, received the CE mark for its InsulCheck DOSE, a single-unit add-on device for insulin pen injectors
In August 2023, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. submitted the supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking sanction of DARZALEX in combination with Kyprolis and dexamethasone for relapsed/refractory multiple myeloma. If approved this will increase the product portfolio and also revenue generation of the company
In September 2022, Corium, Inc., a biopharmaceutical company, launched ADLARITY, a donepezil transdermal system in the U.S. for treating patients suffering from mild to severe Alzheimer’s
In August 2022, Baxter announced the U.S. FDA Clearance of the Novum IQ Syringe Infusion Pump with Dose IQ Safety Software. The Novum IQ Syringe infusion pumps precisely deliver small amounts of fluid at low rates, frequently in pediatric, neonatal or anesthesia care settings
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future
